Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk

Affiliations

• ¹ Mary McKillop Institute for Health Research, Catholic University, AustralianMelbourne, Australia. [email protected].
• ² Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK. [email protected].
• ³ MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
• ⁴ NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
• ⁵ Mary McKillop Institute for Health Research, Catholic University, AustralianMelbourne, Australia.
• ⁶ Sahlgrenska Osteoporosis Centre, Institute of Medicine and Clinical Nutrition, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
• ⁷ Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
• ⁸ Odense Patient Data Explorative Network, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
• ⁹ Department of Medicine, McMaster University, Hamilton, Canada.
• ¹⁰ Biochemistry Department, College of Science, Riyadh, Kingdom of Saudi Arabia.
• ¹¹ Quantify Research, Stockholm, Sweden.
• ¹² Research Unit in Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
• ¹³ School of Medicine, University of Galway, Galway, Ireland.
• ¹⁴ Clinical Epidemiology Research Unit, Hospital Infantil de Mexico "Federico Gomez", Mexico City, Mexico.
• ¹⁵ Faculty of Medicine of National Autonomous University of Mexico (Universidad, Nacional Autónoma de México), Mexico City, Mexico.
• ¹⁶ NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
• ¹⁷ Victoria University of Wellington, Wellington, New Zealand.
• ¹⁸ Metabolic Bone Diseases Unit, Department of Internal Medicine, Hospital Universitario Fundación Jiménez Díaz, Universidad Autónoma Madrid, Madrid, Spain.
• ¹⁹ Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Styria, Austria.
• ²⁰ Carol Davila University of Medicine, Bucharest, Romania.
• ²¹ Department of Endocrinology & Bone Metabolism, National Institute of Endocrinology, Bucharest, Romania.
• ²² Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
• ²³ International Institute for Biosensing, University of Minnesota, Minneapolis, USA.
• ²⁴ Department of Rheumatology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands.
• ²⁵ New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, USA.
• ²⁶ Multidisciplinary Osteoporosis Forum, Warsaw, Poland, Poland.
• ²⁷ McMaster University, Hamilton, ON, Canada.
• ²⁸ Protein Research Chair, Biochemistry Dept, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.
• ²⁹ Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
• ³⁰ Laboratory of Epidemiology and Population Sciences, National Institute On Aging, Baltimore, MD, USA.
• ³¹ Department of Medicine, Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
• ³² Translational Gerontology Branch, National Institute On Aging Intramural Research Program, Baltimore, MD, USA.
• ³³ University of Las Palmas de Gran Canaria, Grand Canaries, Spain.
• ³⁴ INSERM UMR 1033, University of Lyon, Hospital Edouard Herriot, Lyon, France.
• ³⁵ MRC Unit The Gambia, London School of Hygiene and Tropical Medicine, Banjul, The Gambia.
• ³⁶ Department of Preventive Medicine for Locomotive Organ Disorders, The University of Tokyo Hospital, Tokyo, Japan.
• ³⁷ Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.
• ³⁸ Mellanby Centre for Musculoskeletal Research, MRC Versus Arthritis Centre for Integrated Research in Musculoskeletal Ageing, University of Sheffield, Sheffield, UK.